Aligos Therapeutics Inc
NASDAQ:ALGS

Watchlist Manager
Aligos Therapeutics Inc Logo
Aligos Therapeutics Inc
NASDAQ:ALGS
Watchlist
Price: 19.46 USD -0.61% Market Closed
Market Cap: 120m USD
Have any thoughts about
Aligos Therapeutics Inc?
Write Note

Aligos Therapeutics Inc
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Aligos Therapeutics Inc
Free Cash Flow Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Aligos Therapeutics Inc
NASDAQ:ALGS
Free Cash Flow
-$79m
CAGR 3-Years
-1%
CAGR 5-Years
-56%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Free Cash Flow
$15.6B
CAGR 3-Years
-10%
CAGR 5-Years
4%
CAGR 10-Years
13%
Gilead Sciences Inc
NASDAQ:GILD
Free Cash Flow
$10B
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
0%
Amgen Inc
NASDAQ:AMGN
Free Cash Flow
$6.3B
CAGR 3-Years
-7%
CAGR 5-Years
-7%
CAGR 10-Years
-1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Free Cash Flow
-$1.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-13%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Free Cash Flow
$3.3B
CAGR 3-Years
-15%
CAGR 5-Years
11%
CAGR 10-Years
20%

See Also

What is Aligos Therapeutics Inc's Free Cash Flow?
Free Cash Flow
-79m USD

Based on the financial report for Dec 31, 2023, Aligos Therapeutics Inc's Free Cash Flow amounts to -79m USD.

What is Aligos Therapeutics Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-56%

Over the last year, the Free Cash Flow growth was 2%. The average annual Free Cash Flow growth rates for Aligos Therapeutics Inc have been -1% over the past three years , -56% over the past five years .

Back to Top